Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment

NCT02624726 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: 5 Fluorouracil
DRUG: Leucovorin
DRUG: Irinotecan
DRUG: Aflibercept

Sponsor

Hellenic Oncology Research Group